Jada Pinkett Smith Reveals Psilocybin Helped Her Overcome ‘Crippling Depression’ in ‘Red Table Talk’ About Psychedelics
Will Smith’s wife, and her son, Jaden, lead a “Red Table Talk” about psychedelics with author Michael Pollan and other guests.
depression
Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David J. Hellerstein, who was evaluating Compass Pathways’ novel drug formulation COMP360.
COVID-19 Pandemic Study of Ketamine Therapy Amplifies Antidepressant Potential
Study authors even believe “treating serious mental illness may reduce adverse outcomes related to COVID-19.”
Psychedelic Business Spotlight: July 2, 2021
This week in psychedelic business news: Companies embrace the psychedelic aspects of VR, Braxia trains therapists in psychedelic best practices, and Allied gears up to provide its psychedelic formulation to PTSD patients.
New Treatment Potential for Depressed, Suicidal Patients With Ketamine, Says Expert
There’s new hope for depressed and suicidal patients with ketamine therapy, says University of Alabama doctor Richard C. Shelton.
Psilocybin As Effective as Lexapro in Treating Depression: Study
The first study of its kind compares psilocybin and the antidepressant Lexapro in treating depression. The results are promising.
Ketamine Therapy Shows Benefits in Treating Depression Related to Childhood Abuse
Adults with depression who were abused or neglected as children…
Small Pharma Clinical Trials to Study DMT for Treatment-Resistant Depression
Small Pharma is going into clinical trials to look at DMT for depression relief. The UK company says it believes benefits will be immediate.
Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression
Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.
End of content
End of content